Literature DB >> 29183959

Stereotactic EEG-guided laser interstitial thermal therapy for mesial temporal lobe epilepsy.

James X Tao1, Shasha Wu1, Maureen Lacy2, Sandra Rose1, Naoum P Issa1, Carina W Yang3, Katherine E Dorociak2, Maria Bruzzone1, Jisoon Kim1, Ahmad Daif1, Jason Choi4, Vernon L Towle1, Peter C Warnke4.   

Abstract

OBJECTIVE: To determine the outcomes of combined stereo-electroencephalography-guided and MRI-guided stereotactic laser interstitial thermal therapy (LITT) in the treatment of patients with drug-resistant mesial temporal lobe epilepsy (mTLE).
METHODS: We prospectively assessed the surgical and neuropsychological outcomes in 21 patients with medically refractory mTLE who underwent LITT at the University of Chicago Medical Center. We further compared the surgical outcomes in patients with and without mesial temporal sclerosis (MTS).
RESULTS: Of the 21 patients, 19 (90%) underwent Invasive EEG study and 11 (52%) achieved freedom from disabling seizures with a mean duration of postoperative follow-up of 24±11 months after LITT. Eight (73%) of 11 patients with MTS achieved freedom from disabling seizures, whereas 3 (30 %) of 10 patients without MTS achieved freedom from disabling seizures. Patients with MTS were significantly more likely to become seizure-free, as compared with those without MTS (P=0.002). There was no significant difference in total ablation volume and the percentage of the ablated amygdalohippocampal complex between seizure-free and non-seizure-free patients. Presurgical and postsurgical neuropsychological assessments were obtained in 10 of 21 patients. While there was no group decline in any neuropsychological assessment, a significant postoperative decline in verbal memory and confrontational naming was observed in individual patients.
CONCLUSIONS: MRI-guided LITT is a safe and effective alternative to selective amygdalohippocampectomy and anterior temporal lobectomy for mTLE with MTS. Nevertheless, its efficacy in those without MTS seems modest. Large multicentre and prospective studies are warranted to further determine the efficacy and safety of LITT. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  anterior temporal lobectomy; drug resistant epilepsy; laser ablation; selective amygadalohippocampectomy; temporal lobe epilepsy

Mesh:

Year:  2017        PMID: 29183959     DOI: 10.1136/jnnp-2017-316833

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  8 in total

1.  Effects of surgical targeting in laser interstitial thermal therapy for mesial temporal lobe epilepsy: A multicenter study of 234 patients.

Authors:  Chengyuan Wu; Walter J Jermakowicz; Srijata Chakravorti; Iahn Cajigas; Ashwini D Sharan; Jonathan R Jagid; Caio M Matias; Michael R Sperling; Robert Buckley; Andrew Ko; Jeffrey G Ojemann; John W Miller; Brett Youngerman; Sameer A Sheth; Guy M McKhann; Adrian W Laxton; Daniel E Couture; Gautam S Popli; Alexander Smith; Ashesh D Mehta; Allen L Ho; Casey H Halpern; Dario J Englot; Joseph S Neimat; Peter E Konrad; Elliot Neal; Fernando L Vale; Kathryn L Holloway; Ellen L Air; Jason Schwalb; Benoit M Dawant; Pierre-Francois D'Haese
Journal:  Epilepsia       Date:  2019-05-21       Impact factor: 5.864

2.  The utility of diffusion tractography for speech preservation in laser ablation of the dominant insula: illustrative case.

Authors:  Timothy J Kaufmann; Vance T Lehman; Lily C Wong-Kisiel; Panagiotis Kerezoudis; Kai J Miller
Journal:  J Neurosurg Case Lessons       Date:  2021-05-10

3.  Multicenter validation of automated trajectories for selective laser amygdalohippocampectomy.

Authors:  Vejay N Vakharia; Rachel E Sparks; Kuo Li; Aidan G O'Keeffe; Fernando Pérez-García; Lucas G S França; Andrew L Ko; Chengyuan Wu; Joshua P Aronson; Brett E Youngerman; Ashwini Sharan; Guy McKhann; Sebastien Ourselin; John S Duncan
Journal:  Epilepsia       Date:  2019-08-07       Impact factor: 5.864

4.  LncRNA ILF3-AS1 mediated the occurrence of epilepsy through suppressing hippocampal miR-212 expression.

Authors:  Xiaodong Cai; Ling Long; Chao Zeng; Guanzhong Ni; Yangyang Meng; Qiang Guo; Ziyi Chen; Zhong Li
Journal:  Aging (Albany NY)       Date:  2020-05-13       Impact factor: 5.682

5.  Mechanisms and Risk Factors Contributing to Visual Field Deficits following Stereotactic Laser Amygdalohippocampotomy.

Authors:  Natalie L Voets; Ivan Alvarez; Deqiang Qiu; Christopher Leatherday; Jon T Willie; Stamatios Sotiropoulos; Ezequiel Gleichgerrcht; Leonardo Bonilha; Nigel P Pedersen; Nadja Kadom; Amit M Saindane; Robert E Gross; Daniel L Drane
Journal:  Stereotact Funct Neurosurg       Date:  2019-10-16       Impact factor: 1.875

6.  Surgical Outcomes and EEG Prognostic Factors After Stereotactic Laser Amygdalohippocampectomy for Mesial Temporal Lobe Epilepsy.

Authors:  Shasha Wu; Naoum P Issa; Maureen Lacy; David Satzer; Sandra L Rose; Carina W Yang; John M Collins; Xi Liu; Taixin Sun; Vernon L Towle; Douglas R Nordli; Peter C Warnke; James X Tao
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

7.  Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy.

Authors:  Elysa Widjaja; Tina Papastavros; Beate Sander; Carter Snead; Petros Pechlivanoglou
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

8.  Resective, Ablative and Radiosurgical Interventions for Drug Resistant Mesial Temporal Lobe Epilepsy: A Systematic Review and Meta-Analysis of Outcomes.

Authors:  Kajol Marathe; Ali Alim-Marvasti; Karan Dahele; Fenglai Xiao; Sarah Buck; Aidan G O'Keeffe; John S Duncan; Vejay N Vakharia
Journal:  Front Neurol       Date:  2021-12-09       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.